<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV style="font-size: 10pt">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>

<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P align="center" style="font-size: 10pt"><B>Date of Report (Date of earliest event reported): February 4, 2008</B>

<P align="center">

<P align="center" style="font-size: 24pt"><B>Health Grades, Inc.<BR></B>
<FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>Delaware</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>0-22019</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>62-1623449</B></TD>
</TR>
<TR valign="top">
    <TD>(State or other Jurisdiction of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD>(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD>(IRS Employer Identification No.)</TD>
</TR>
</TABLE>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>500 Golden Ridge Road, Suite 100<BR>Golden, Colorado<BR></B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>80401</B></TD>
</TR>
<TR valign="top">
    <TD>(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD>(Zip Code)</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <B>(303) 716-0041</B>


<TABLE border="0" width="30%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="100%">&nbsp;</TD>
</TR>
<TR>
    <TD nowrap style="border-bottom: 1px solid #000000"><B>&nbsp;</B></TD>
</TR>
<TR>
    <TD nowrap>(Former name or former address if changed since last report.)</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

<P align="left" style="font-size: 10pt">
<FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>
<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>Item&nbsp;5.02.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.</B></DIV></TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">On February&nbsp;4, 2009, Sarah Loughran provided notice of her intent to resign as Executive Vice President of
Health Grades, Inc. (the &#147;Company&#148;), effective March&nbsp;9, 2009. Ms.&nbsp;Loughran was a &#147;named executive officer&#148; in the
Company&#146;s Proxy Statement related to the Company&#146;s 2008 Annual Meeting of Stockholders. Ms.&nbsp;Loughran has elected
to step down from her position for personal reasons and will take on a new part-time role with the Company as Vice
President, New Product Development for Provider Services. Ms Loughran has served as executive vice president
since July&nbsp;2004, and in this role has helped drive HealthGrades&#146; mission to guide America to better healthcare.
The Company&#146;s board of directors wishes to thank Ms.&nbsp;Loughran for her hard work and service to the Company over
the last ten years.</DIV></TD>
</TR>

</TABLE>


<P align="justify" style="font-size: 10pt; margin-left: 4%">The board of directors of the Company has appointed Dr.&nbsp;Samantha Collier to replace Ms.&nbsp;Loughran as Chief Medical
Officer/Executive Vice President, effective March&nbsp;9, 2009. Dr.&nbsp;Collier is a board certified internist and is
currently serving as the Company&#146;s Senior Vice President of Medical Affairs/Chief Medical Officer. Dr.&nbsp;Collier
has significantly contributed to the Company&#146;s Provider Services team since March&nbsp;2002 and has led the
HealthGrades Clinical Excellence Research &#038; Consulting Group for the last five years.

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="justify" style="font-size: 10pt"><B>SIGNATURE</B>


<P align="justify" style="font-size: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.


<P align="justify" style="font-size: 10pt; margin-left: 48%"><B>HEALTH GRADES, INC.</B>
<BR>
(Registrant)


<P align="justify" style="font-size: 10pt; margin-left: 48%">By: <U><B>/</B>s/ Allen
Dodge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allen Dodge
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice
President
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Chief
Financial Officer


<P align="justify" style="font-size: 10pt">Dated: February&nbsp;10, 2009


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">3




</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c80826e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 7906}]
{"company-data": {"conformed-name": "HEALTH GRADES INC", "cik": "0001027915", "assigned-sic": "7389", "irs-number": "621623449", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-22019", "film-number": "09586127"}, "business-address": {"street1": "500 GOLDEN RIDGE RD", "street2": "SUITE 100", "city": "GOLDEN", "state": "CO", "zip": "80401", "phone": "3037160041"}, "mail-address": {"street1": "500 GOLDEN RIDGE RD", "street2": "SUITE 100", "city": "GOLDEN", "state": "CO", "zip": "80401"}, "former-company": [{"former-conformed-name": "HEALTHGRADES COM INC", "date-changed": "20000118"}, {"former-conformed-name": "SPECIALTY CARE NETWORK INC", "date-changed": "19961210"}]}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 4, 2008
Health Grades, Inc.
(Exact name of registrant as specified in its charter)
Delaware
0-22019
62-1623449
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 Golden Ridge Road, Suite 100
Golden, Colorado
80401
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(303) 716-0041
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
(b)
On February 4, 2009, Sarah Loughran provided notice of her intent to resign as Executive Vice President of
Health Grades, Inc. (the "Company"), effective March 9, 2009. Ms. Loughran was a "named executive officer" in the
Company's Proxy Statement related to the Company's 2008 Annual Meeting of Stockholders. Ms. Loughran has elected
to step down from her position for personal reasons and will take on a new part-time role with the Company as Vice
President, New Product Development for Provider Services. Ms Loughran has served as executive vice president
since July 2004, and in this role has helped drive HealthGrades' mission to guide America to better healthcare.
The Company's board of directors wishes to thank Ms. Loughran for her hard work and service to the Company over
the last ten years.
The board of directors of the Company has appointed Dr. Samantha Collier to replace Ms. Loughran as Chief Medical
Officer/Executive Vice President, effective March 9, 2009. Dr. Collier is a board certified internist and is
currently serving as the Company's Senior Vice President of Medical Affairs/Chief Medical Officer. Dr. Collier
has significantly contributed to the Company's Provider Services team since March 2002 and has led the
HealthGrades Clinical Excellence Research & Consulting Group for the last five years.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
HEALTH GRADES, INC.
(Registrant)
By:
/
s/ Allen
Dodge
Allen Dodge
Executive Vice
President
and Chief
Financial Officer
Dated: February 10, 2009